Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C1-esterase Inhibitor in Trauma Patients with Femur or Pelvic Fracture
NCT01275976Phase 3Terminated
- Start
- Apr 2012
- Primary completion
- Feb 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of c1-esterase inhibitor in systemic inflammation, acute respiratory distress syndrome (ARDS), multiple organ dysfunction syndrome (MODS), sepsis. Started Apr 2012; status: terminated.
02
Drugs
c1-esterase inhibitor
03
Conditions
systemic inflammationacute respiratory distress syndrome (ARDS)multiple organ dysfunction syndrome (MODS)sepsis
Beyond the preview
Go deeper on NCT01275976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01275976.